MétaCan
Menu
← Back to cohort

Prognostic significance of the proliferation signature in mantle cell lymphoma measured using digital gene expression in formalin-fixed paraffin-embedded tissue biopsies.

2016· article· en· W2891440744 on OpenAlexaff
David W. Scott, Pau Abrisqueta, George W. Wright, Pedro Jares, Graham W. Slack, Anja Mottok, Cristina Royo, Guillem Clot, Magda Pinyol, Merrill Boyle, Diego Villa, Christian Steidl, Joseph M. Connors, Andreas Rosenwald, Louis M. Staudt, Lisa M. Rimsza, Randy D. Gascoyne, Elı́as Campo

Bibliographic record

VenueJournal of Clinical Oncology · 2016
Typearticle
Languageen
FieldMedicine
TopicLymphoma Diagnosis and Treatment
Canadian institutionsBC Cancer Agency
Fundersnot available
KeywordsMedicineGene signatureMantle cell lymphomaOncologyBiopsyGene expressionLog-rank testGene expression profilingPathologyLymph nodeCancer researchLymphomaInternal medicineGeneSurvival analysisBiology

Abstract

fetched live from OpenAlex

7510 Background: Mantle cell lymphoma (MCL) is a group of aggressive B-cell lymphomas displaying heterogeneous outcomes after treatment. A number of prognostic indices have been described. A powerful biomarker, the “proliferation signature”, was developed using gene expression in fresh frozen material in 2003 (Rosenwald et al Cancer Cell). Here we describe the training and validation of a new assay that measures the proliferation signature in RNA derived from routinely available formalin-fixed paraffin-embedded (FFPE) biopsies. Methods: FFPE biopsies were used to train an assay on the NanoString platform using Affymetrix U133 microarray gene expression in matched fresh frozen biopsies as a gold standard. The locked assay (including gene coefficients and score thresholds to define high, intermediate and low risk groups) was then applied to pre-treatment FFPE lymph node biopsies from an independent cohort of 110 patients uniformly treated with R-CHOP chemotherapy at the BC Cancer Agency. In 59 of these patients, aged 65 years or younger, there was intention-to-treat with an autologous stem cell transplant to consolidate response (the “ASCT-ITT” group). The MIPI was available for 95 patients. Results: The MCL55 assay, containing a 16-gene proliferation signature, yielded gene expression of sufficient quality to assign a score and risk group in 108/110 (98%) archival FFPE biopsies and assigned patients to high (26% of patients), intermediate (29%), and low (45%) risk groups with significantly different overall survival (OS); median OS of 1.1, 2.6 and 8.6 years, respectively (logrank for trend P<0.001). Within the ASCT-ITT group the median OS in these 3 risk groups were 1.4 years, 5.9 years, and not reached, respectively (logrank for trend P<0.001). In multivariate analysis, the risk groups assigned by the MCL55 assay and by the MIPI were independently associated with OS in the total cohort (P<0.001 for both variables). Conclusions: The newly developed and validated MCL55 assay for FFPE biopsies uses the proliferation signature to define groups of patients with MCL with significantly different OS independent of the MIPI.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.001
Threshold uncertainty score0.003

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.071
GPT teacher head0.382
Teacher spread0.311 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations3
Published2016
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Clinical Oncology→Same topicLymphoma Diagnosis and Treatment→French-language works237,207→